Patents by Inventor Fengjun LUO

Fengjun LUO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compound for targeted degradation of BTK and anti-tumour use thereof
    Patent number: 12624042
    Abstract: Provided in the present invention are a compound for the targeted degradation of BTK and the anti-tumor use thereof. In particular, in the present invention, a series of compounds are prepared and screened, the inhibitory and degradation activities of said compounds against Bruton's tyrosine kinase (BTK) are verified, and finally a compound with good druggability is found. The compound can be used for treating diseases associated with the activity or the expression quantity of Bruton's tyrosine kinase (BTK).
    Type: Grant
    Filed: October 26, 2021
    Date of Patent: May 12, 2026
    Assignee: SHANGHAI MEIZER PHARMACEUTICALS CO., LTD.
    Inventors: Yongzhi Shu, Fengjun Luo
  • COMPOUND FOR TARGETED DEGRADATION OF BTK AND ANTI-TUMOUR USE THEREOF
    Publication number: 20240002389
    Abstract: Provided in the present invention are a compound for the targeted degradation of BTK and the anti-tumor use thereof. In particular, in the present invention, a series of compounds are prepared and screened, the inhibitory and degradation activities of said compounds against Bruton's tyrosine kinase (BTK) are verified, and finally a compound with good druggability is found.
    Type: Application
    Filed: October 26, 2021
    Publication date: January 4, 2024
    Inventors: Yongzhi SHU, Fengjun LUO